Previous 10 | Next 10 |
Inotiv, Inc. (NOTV) Q3 2022 Earnings Conference Call August 10, 2022 5:00 PM ET Company Participants Devin Sullivan - The Equity Group Inc. Bob Leasure - President and Chief Executive Officer Beth Taylor - Chief Financial Officer John Sagartz - Chief Strategy...
Inotiv press release ( NASDAQ: NOTV ): Q3 GAAP EPS of -$0.15 misses by $0.13 . Revenue of $172.7M (+654.5% Y/Y) beats by $30.97M . For further details see: Inotiv GAAP EPS of -$0.15 misses by $0.13, revenue of $172.7M beats by $30.97M
WEST LAFAYETTE, Ind., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and de...
Headwaters Capital Management is an actively managed, concentrated investment strategy focused on small and mid-capitalization stocks. The Headwaters Capital portfolio declined -20.5% compared to a -16.9% decline for the Russell Mid Cap index in Q2 2022. I don't know where the mar...
WEST LAFAYETTE, Ind., Aug. 01, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and de...
The shares of the contract research organization Inotiv ( NASDAQ: NOTV ) jumped ~16% in the morning hours after the company announced a settlement with the U.S. government over an investigation into its production facility in Cumberland, Virginia. Per the terms of the ...
Gainers: Inotiv ( NOTV ) +18% . IO Biotech ( IOBT ) +16% . SOPHiA GENETICS ( SOPH ) +10% . Apyx Medical ( APYX ) +9% . Rhythm Pharmaceuticals ( RYTM ) +9% . Losers: Regulus Therapeutics ( RGLS ) -14% . Aerovate...
WEST LAFAYETTE, Ind., July 18, 2022 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, “We”, “Our” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and de...
***Please contact fmoore@moorekuehn.com New York, New York--(Newsfile Corp. - July 1, 2022) - Moore Kuehn, PLLC, a securities law firm located on Wall Street, is investigating potential claims involving directors and officers of Inotiv Inc. (NASDAQ: NOTV) regarding possible ...
New York, New York--(Newsfile Corp. - June 27, 2022) - Levi & Korsinsky, LLP notifies investors in Inotiv, Inc. (NASDAQ: NOTV) ("Inotiv" or the "Company") of a class action securities lawsuit. The lawsuit on behalf of Inotiv investors has been commenced in the the United State...
News, Short Squeeze, Breakout and More Instantly...
WEST LAFAYETTE, Ind., June 10, 2024 (GLOBE NEWSWIRE) -- Inotiv, Inc. (Nasdaq: NOTV) (the “Company” or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and development services and research models and rela...